Ameet Mallik finds green­er turf as new head of ADC Ther­a­peu­tics fol­low­ing ill-fat­ed first CEO stint

Around a year ago, Ameet Mallik left his post at No­var­tis, where he had spent the last 16 years, to cham­pi­on a drug for metasta­t­ic pan­cre­at­ic can­cer as CEO at Rafael Hold­ings. How­ev­er, just half a year in, the com­pa­ny took a nose­dive as that drug failed a Phase III tri­al, and Mallik, among many oth­ers, left his post at Rafael Hold­ings.

Now Mallik will be start­ing fresh as CEO of ADC Ther­a­peu­tics, the com­pa­ny an­nounced to­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER